Company Profile

Neuronautics Inc
Profile last edited on: 11/28/12      CAGE: 4H5U7      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1997
First Award
2001
Latest Award
2007
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1801 Maple Avenue Suite 6120
Evanston, IL 60201
   (847) 491-3271
   N/A
   N/A
Location: Single
Congr. District: 09
County: Cook

Public Profile

Neuronautics, Inc. develops therapeutic and diagnostic agents for Alzheimer’s disease and other related neurodegenerative diseases. It designs a drug cocktail that inhibits the fibrillar pathology to prevent or slow Alzheimer's disease progression. The company’s technology is based on preventing the formation of tau polymers comprising the fibrillar pathology in the brains of patients with Alzheimer's dise

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2007 2 NIH $2,539,011
Project Title: Drug Discovery for Alzheimer's Disease

Key People / Management

  Abraha Aida

  Arpita Das

  Sam Khatami -- Vice President of Operations, Director and Co-Founder:

Company News

There are no news available.